Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs

E-ISSN： 1873-5592|7|12|1671-1680

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.12, 2006-12, pp. : 1671-1680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Analysis of CYP2D6 Polymorphism in Indian Populations and its Pharmacogenetic Implications

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 2, 2014-06 ,pp. : 123-132

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite

Genetic variations in cytochrome P450 (CYP) 2D6 activity may have important clinical consequences for some drugs

Drugs & Therapy Perspectives, Vol. 26, Iss. 5, 2010-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

By Dandara Collet Mutowembwa Masimirembwa Collen Magimba Ayoub Sayi Jane Kaaya Sylvia Sommers De K. Snyman J.R. Hasler Julia Anne

European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. : 11-17

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 241-250

Bentham Science Publishers

Access to resources Recommend Favorite